LOADING
Basal Cell Carcinoma VA Disability Rating is rated by the U.S. Department of Veterans Affairs under DC 7818 of 38 C.F.R. § 4.118 across 4 severity tiers (60% -- >40% of body or exposed areas, or constant systemic therapy / 30% -- 20-40% of body or systemic therapy 6+ weeks / 10% -- 5-20% of body / 0% -- <5% of body). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.
Basal cell carcinoma (DC 7818) rates 100% during active malignancy. After treatment, rated on residual disfigurement. Sun exposure during military service establishes nexus.
Basal Cell Carcinoma (DC 7818) is evaluated under 38 C.F.R. § 4.118 using the skin rating framework. Because it is rated by analogy to the general schedule, the 4 levels below describe the body-system criteria the VA applies — the percentage assigned to Basal Cell Carcinoma depends on the specific findings (range of motion, frequency, severity, or functional loss) documented at the C&P exam and in the medical record.
Rating criteria reference 38 C.F.R. Part 4 (Schedule for Rating Disabilities). This entry has not yet undergone editorial review against the live regulation text — consult the authoritative source directly before relying on the criteria shown.